19 results about "Fenugreeks" patented technology

The present invention relates to an oral extract composition comprising Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.) extract composition, and its process of preparation. Also relates to the oral extract composition formulation comprising with synergistic combinations of the Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.) in suitable doses and at least one nutraceutically and / or pharmaceutically accepted excipient for, improvement, and maintenance of women health more preferably in improving of hot flashes, night sweats, poor sleep, anxiety, sexual dysfunction, mood changes, Genitourinary symptoms in overall improving the quality of life, serum estradiol, progesterone, follicle stimulating hormone (FSH), and cortisol during the period of menopause (perimenopause and menopause). The oral extract composition formulation comprising with synergistic combinations of the Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.) in suitable doses and at least one nutraceutically and / or pharmaceutically accepted excipient is used for improving Brain-derived neurotrophic factor (BDNF) levels in women during the period of menopause. The present invention, further related to the extraction process of Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.), also provides the process for the preparation of formulation composition. This invention further relates to the extraction process from Shatavari (Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.) either as individual herbs or co-extraction of the two herbs or mixing the extracts at various stages of the individual extracts.

This invention discloses a biphasic combined Lewis acid hydrolysis method for extracting diosgenin from fenugreek, belonging to the field of natural product extraction technology. The extraction method disclosed in this invention includes: defatting fenugreek raw material, mixing it with a biphasic reaction system composed of Lewis acid, concentrated hydrochloric acid, methanol, water, and petroleum ether, and carrying out a hydrolysis reaction under heating conditions. After the reaction, the organic phase is separated, concentrated, and dried to obtain diosgenin. This invention innovatively introduces a Lewis acid catalyst into the biphasic acid hydrolysis system of fenugreek, achieving significant results such as a 25% reduction in reaction time, a 50% reduction in concentrated hydrochloric acid usage, and a 25% reduction in water usage while ensuring the extraction rate of diosgenin. This method has advantages such as mild conditions, low acid consumption, short processing time, and environmental friendliness, and is suitable for the large-scale green production of diosgenin.

The description of the present invention discloses a taste-enhancing composition capable of enhancing the taste of a food product by being blended in the food product, and a method for producing the taste-enhancing composition. The present disclosure relates to a taste-enhancing composition and a method for producing the same, the taste-enhancing composition containing one or more heat-treated spices selected from the group consisting of heat-treated fenugreek, heat-treated garlic, and heat-treated capsicum, wherein the heat-treated fenugreek is obtained by subjecting fenugreek to a heat treatment under one or more conditions selected from a1) a condition in which the heating temperature is 165°C or higher and the heating value is 100 or higher, b1) a condition in which oil is also present, and c1) a condition involving pressurized sealing.

The invention relates to the field of repair product preparation, in particular to a novel nano-antibacterial skin repair product for preventing hpv viruses. The formula is prepared from the following raw materials by weight: 0.80 to 4.50 g of purified water, 0.008 to 0.150 g of carbomer, 0.01 to 0.80 g of fenugreek oil, 0.01 to 0.30 g of oat beta glucan, 0.003 to 0.400 g of folium artemisiae argyi extracting solution, 0.01 to 0.40 g of herba portulacae extracting solution, 0.006 to 0.420 g of herba violae extracting solution, 0.001 to 0.200 g of herba lophatheri extracting solution, 0.007 to 0.300 g of herba taraxaci extracting solution, 0.008 to 0.220 g of rhizoma paridis chinensis extracting solution, 0.01 to 0.40 g of herba leonuri extracting solution, 0.0005 to 0.0300 g of nano silver and 0.008 to 0.150 g of borneol. The adhesive comprises the following components by weight: 0.01 to 0.30 g of sodium carboxymethyl cellulose, 0.008 to 0.220 g of lubrajel, 0.007 to 0.300 g of benzoyl peroxide, and 0.0005 to 0.0300 g of a cross-linking agent. The invention has the following beneficial effects: the ointment comprises a plurality of plant extracts, has no irritation to vagina, is safe and has no side effect; the carried antiviral and antibacterial components can rapidly permeate into the skin to protect mucous membrane cells from being damaged by viruses; skin tissues can be quickly repaired, and wound healing and regeneration capacity is improved; various plant extracts in the gel can also improve the immunity of the organism and can achieve a good antiviral effect.

The traditional Chinese medicine composition is prepared from the following components in parts by weight: 6 to 12 parts of herba epimedii, 10 to 30 parts of radix astragali seu hedysari, 6 to 12 parts of herba cistanche, 4 to 8 parts of radix bupleuri, 6 to 12 parts of ramulus cinnamomi, 10 to 30 parts of caulis spatholobi, 10 to 15 parts of radix paeoniae alba, 6 to 12 parts of semen trigonellae and 10 to 40 parts of corn stigma. According to the traditional Chinese medicine composition disclosed by the invention, all the medicines are combined to achieve the effects of warming yang, tonifying qi, promoting blood circulation, inducing diuresis, warming and tonifying kidney yang in lower jiao and stirring qi in triple jiao.

Food supplement characterized by containing an active ingredient consisting of - 18 to 19 wt% green tea extract, of which 45 to 55 wt% of this extract consists of polyphenols and 6 to 7 wt% of this extract consists of theine, - 18 to 19% w / w extract from Cambodian Garcinia 10:1, - 14 to 15 wt% extract from red Moro orange 20:1, - 14 to 15 wt% extract from Gymnema sylvestre, of which 25 wt% of this extract consists of gymnemic acids, - 7 to 8 wt% extract of Coleus forskohlii, of which 5 wt% of this extract consists of forskolin, - 7 to 8% by weight berberine from Indian barberry, - 7 to 8% w / w extract from Paraguayan holly 10:1, - 7 to 8% w / w extract of fenugreek 10:1, - 3 to 4 wt% saffron extract, of which 0.1 to 0.2 wt% this extract consists of safranal, and max. 0.005 wt% chromium.

Composition for use in a method for preventing the onset or treating the symptoms of gastritis in equines, said method comprising a step of administering a therapeutically effective amount of the composition to an equine, wherein the composition comprises: an amount of dehydrated sweet potato; an amount of β-glucan (BG) powder; an amount of dried St. John's wort (Hypericum perforatum) flowers; an amount of fenugreek seed powder (Trigonella foenum-grecum); an amount of carob pod powder (Ceratonia siliqua). IPC=A23K

The invention relates to a composition containing i) a DPP-4 inhibitor selected from an extract of dandelion (Taraxacum officinale), an extract of white mulberry (Morus alba), an extract of bitter melon (Momordica charantia), a hydrolysate of yeast (Saccharomyces cerevisiae), an extract of garlic (Allium sativum), an extract of grape (Vitis vinifera), an extract of turmeric (Curcuma longa), an extract of horseradish tree (Moringa oleifera) and an extract of fenugreek (Trigonella foenum-graecum); and ii) a GLP-1 analogue selected from a hydrolysate of yeast (Saccharomyces cerevisiae), a white mulberry (Morus alba) extract, a yerba mate (Ilex paraguariensis) extract, an Arabica coffee (Coffea arabica) extract, a purslane (Portulaca oleracea) extract, a bitter melon (Momordica charantia) extract, a lager flower (Lagerstroemia speciosa) extract, an apple (Malus domestica) extract, a cinnamon (Cinnamomum verum) extract and a fenugreek (Trigonella foenum-graecum) extract; and iii) a GLP-1 secretion enhancer selected from inulin, gum arabic, an extract of bitter melon (Momordica charantia), an extract of purslane (Portulaca oleracea), an extract of common barberry (Berberis vulgaris), an extract of Arabica coffee (Coffea arabica), an extract of Siberian angelica (Angelica dahurica), an extract of turmeric (Curcuma longa) and an extract of fenugreek (Trigonella foenum-graecum), where at least one ingredient is selected from each group i)-iii) and a total of at least three different ingredients are selected.

The present disclosure relates to a dietary fiber composition and a process for its preparation. The dietary fiber composition comprises fenugreek fiber, natural fiber, plant extract, and additives. The dietary fiber composition of the present disclosure has excellent water and oil holding capacities. The dietary fiber composition of the present disclosure helps in controlling appetite, weight management, reducing food intake, and maintaining appetite hormones.

The invention discloses a composition containing recombinant humanized superoxide dismutase as well as a preparation method and application thereof, and belongs to the technical field of cosmetics. The composition comprises recombinant humanized superoxide dismutase, a fenugreek fruit extract, a rhodiola rosea extract and a lentil fruit extract. The three plant extract components of the fenugreek fruit extract, the rhodiola rosea extract and the lentil fruit extract can synergistically improve the high temperature resistance and strong acid and alkali resistance activity of the recombinant humanized superoxide dismutase, and can achieve the effects of whitening, resisting wrinkles and tightening; experiments prove that the superoxide dismutase subjected to recombinant expression has better purity and biological activity, so that the composition containing the recombinant humanized superoxide dismutase has a wide market application prospect.

The invention discloses a compound K2 extracted from fenugreek leaves and application of the compound K2 in preparation of a medicine for treating liver injury. The invention provides an application of a compound K2 in preparation of drugs. The medicine is used for preventing and / or treating liver injury. The invention also provides application of the compound K2 in preparation of a product. The product has the function of inhibiting liver cell injury. The invention also provides a method for preparing the compound K2, which comprises the following steps: taking fenugreek leaves as a raw material, and extracting and separating to obtain the compound K2. The compound K2 is a compound shown in a formula (V).

A method of manufacturing a detangler solution that may be easily prepared, and that helps disentangle, condition, and restore hair to a healthier state is provided. The method includes usage of all natural, plant based, biodegradable, inexpensive, quick, and easy to produce ingredients and involves easy preparation methods. To that end, the detangler solution is made from natural ingredients such as potatoes, onion, rice, fenugreek, and sulfur. More specifically, a combination of potato water, fermented onion water, and fermented rice water, form the base of the detangler solution. Further, ingredients like rosemary, dandelion root, and neem leaves are added for additional benefits. Furthermore, the detangler solutions includes an essential oil of choice for added fragrance. The detangler solution may be left in or washed out with no side effects.

Compositions and methods for improving or regulating GLP-1 levels, or increasing GLP-1 receptors, or reducing GLP-1 degradation, or stimulating GLP-1 secretion in a subject. The composition comprises two or more of the following substances: an effective amount of dihydroberberine (DHB) or berberine, a physiologically acceptable salt, polymer, ester, acid thereof; gymnema sylvestre or gymnemic acid; cinnamon or ceylon cinnamon; nobiletin; or the composition comprises an effective amount of dihydroberberine (DHB), a physiologically acceptable salt, polymer, ester, acid, and one or more of the following substances: β-aminoisobutyric acid, a physiologically acceptable salt, ester; 3-hydroxy-3-methylbutanoic acid, a physiologically acceptable salt, ester; tetrahydrocurcumin, a physiologically acceptable salt, acid, ester; tributyrin; berberine; resveratrol; rhodiola rosea; cinnamon; fenugreek; olive leaf extract; grain of paradise; fruit-vegetable powder; whey protein; or arginine.

The current study was conducted to investigate the possibility Using fenugreek seed extract against cancer cells For humans, two MCF-7 breast lines were also used. For cancer, specifically liver cancer cells And also the Vero HCAM cell line Natural (non-cancerous) as a comparison using Colorimetric. The MTT extract showed an assay Fenugreek seeds exhibit clear activity against alcohol. Staphylococcus and Pseudomonas aeruginosa The alcoholic extract of fenugreek aureus seeds showed Inhibiting and stopping the growth of breast cancer cells without taking Cell death (apoptosis or necrosis) pathway Programmed cell death (or necrosis) occurred in a dose-dependent manner after 72 hours of incubation, while the HCAM extract showed no anticancer effect on cell lines. Fenugreek seed extract showed Vero activity and Antibacterial activity against pathogenic bacteria was tested at various levels. The current MCF-7 study demonstrated the effect of fenugreek seed extract on tissues. HCAM and no effect was observed on the cell line To our knowledge, no study has demonstrated inhibition of human breast cancer cells without the occurrence of apoptosis or necrosis. This finding focuses on the potential benefit of fenugreek extract for the treatment of breast cancer.

The present application relates to a kind of plant conditioning hair dye and its preparation method, the plant conditioning hair dye includes conditioning agent 1.5-2.5% by weight percentage, dyeing agent 2.5-2.9%, humectant 4.5-6%, basic agent 3.8-4.3%, solubilizer 1.4-1.7%, thickening agent 1-1.4%, preservative 0.1-0.5% and the rest deionized water.The hydrolyzed protein, flaxseed extract, radix polygoni multiflori extract, gallnut extract, aloe barbadensis leaf extract, angelica root extract, ginseng root extract and fenugreek fruit extract are used as conditioning agent, the plant conditioning hair dye is prepared by mixing conditioning agent and the rest components, can improve the binding firmness of dyeing agent and hair, make hair dyeing effect better, reduce the damage of hair dye to hair and hair.

The objective is to provide an anti-inflammatory composition with enhanced anti-inflammatory activity that can be safely used on the target subject using food as a raw material. [Solution] Cinnamon or a processed product thereof, At least one selected from the group consisting of cloves, laurel, fenugreek, turmeric, and ginger or processed products thereof, The above problem can be solved by an anti-inflammatory composition containing [the specified ingredient].

The invention discloses a compound Q2 extracted from fenugreek leaves and application of the compound Q2 in preparation of a medicine for treating liver injury. The invention provides an application of a compound Q2 in preparation of drugs. The medicine is used for preventing and / or treating liver injury. The invention also provides application of the compound Q2 in preparation of a product. The product has the function of inhibiting liver cell injury. The invention also provides application of the compound Q2 in preparation of a product for promoting liver cell proliferation. The invention also provides a method for preparing the compound Q2, which comprises the following steps: taking fenugreek leaves as a raw material, and extracting and separating to obtain the compound Q2. The compound Q2 is a compound as shown in a formula (IV).

The invention relates to a composition containing i) a DPP-4 inhibitor selected from an extract of dandelion (Taraxacum officinale), an extract of white mulberry (Morus alba), an extract of bitter melon (Momordica charantia), a hydrolysate of yeast (Saccharomyces cerevisiae), an extract of garlic (Allium sativum), an extract of grape (Vitis vinifera), an extract of turmeric (Curcuma longa), an extract of horseradish tree (Moringa oleifera) and an extract of fenugreek (Trigonella foenum-graecum); and ii) a GLP-1 analogue selected from a hydrolysate from yeast (Saccharomyces cerevisiae), an extract of white mulberry (Morus alba), an extract of Yerba mate (Ilex paraguariensis), an extract of Arabica coffee (Coffea arabica), an extract of purslane (Portulaca oleracea), an extract of bitter melon (Momordica charantia), an extract of queen's crape myrtle (Lagertroemia speciosa), an extract of apple (Malus domestica), an extract of cinnamon (Cinnamomum verum) and an extract of fenugreek (Trigonella foenum-graecum); and iii) a GLP-1 secretion promoter selected from inulin, gum arabic, an extract of bitter melon (Momordica charantia), an extract of purslane (Portulaca oleracea), an extract of common barberry (Berberis vulgaris), an extract of arabica coffee (Coffea arabica), an extract of Dahurian angelica (Angelica dahurica), an extract of turmeric (Curcuma longa) and an extract of fenugreek (Trigonella foenum-graecum), wherein, from each group i)-iii), at least one ingredient is selected and in total at least three different ingredients are selected.